Survival of crizotinib continuation plus brain radiotherapy among ALK positive non-small cell lung cancer (NSCLC) patients with brain metastases during crizotinib treatment.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e21142-e21142
Author(s):  
Guangjian Yang ◽  
Di Ma ◽  
Puyuan Xing ◽  
Haiyan Xu ◽  
Li Junling ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Brain Radiotherapy ◽  
Alk Positive ◽  
Nsclc Patients

Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study

2013 ◽  
Vol 125 (15-16) ◽  
pp. 481-486 ◽  
Author(s):  
Marco Ronald Hassler ◽  
Wolfgang Pfeifer ◽  
Thomas Hendrik Knocke-Abulesz ◽  
Klaus Geissler ◽  
Gabriele Altorjai ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Whole Brain Radiotherapy ◽  
Small Cell ◽  
Small Cell Lung ◽  
Brain Radiotherapy

scholarly journals Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer

Lung Cancer ◽  
2018 ◽  
Vol 119 ◽  
pp. 103-111 ◽  
Author(s):  
C. Burudpakdee ◽  
W. Wong ◽  
A. Seetasith ◽  
F.A. Corvino ◽  
W. Yeh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Economic Impact ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document